{"id": "test_1_0", "text": "In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in @GENE$ and the occurrence of sporadic @DISEASE$ in Chinese patients.", "text_with_entity_marker": "In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in [E1]@GENE$[/E1] and the occurrence of sporadic [E2]@DISEASE$[/E2] in Chinese patients.", "text_with_typed_entity_marker": "In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in [GENE]@GENE$[/GENE] and the occurrence of sporadic [DISEASE]@DISEASE$[/DISEASE] in Chinese patients.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [115, 121], "entity_1_idx_in_text_with_entity_marker": [119, 125], "entity_1_idx_in_text_with_typed_entity_marker": [121, 127], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [153, 162], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_idx_in_text_with_typed_entity_marker": [175, 184], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_1", "text": "The rs42524 polymorphism of @GENE$ could be a genetic risk factor for sporadic @DISEASE$ among individuals of Chinese Han ethnicity.", "text_with_entity_marker": "The rs42524 polymorphism of [E1]@GENE$[/E1] could be a genetic risk factor for sporadic [E2]@DISEASE$[/E2] among individuals of Chinese Han ethnicity.", "text_with_typed_entity_marker": "The rs42524 polymorphism of [GENE]@GENE$[/GENE] could be a genetic risk factor for sporadic [DISEASE]@DISEASE$[/DISEASE] among individuals of Chinese Han ethnicity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [79, 88], "entity_2_idx_in_text_with_entity_marker": [92, 101], "entity_2_idx_in_text_with_typed_entity_marker": [101, 110], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_2", "text": "Surprisingly, the 602S allele is associated with a decreased incidence of @DISEASE$, suggesting that Mycobacterium leprae subverts the @GENE$ system as a mechanism of immune evasion.", "text_with_entity_marker": "Surprisingly, the 602S allele is associated with a decreased incidence of [E1]@DISEASE$[/E1], suggesting that Mycobacterium leprae subverts the [E2]@GENE$[/E2] system as a mechanism of immune evasion.", "text_with_typed_entity_marker": "Surprisingly, the 602S allele is associated with a decreased incidence of [DISEASE]@DISEASE$[/DISEASE], suggesting that Mycobacterium leprae subverts the [GENE]@GENE$[/GENE] system as a mechanism of immune evasion.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [74, 83], "entity_1_idx_in_text_with_entity_marker": [78, 87], "entity_1_idx_in_text_with_typed_entity_marker": [83, 92], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [135, 141], "entity_2_idx_in_text_with_entity_marker": [148, 154], "entity_2_idx_in_text_with_typed_entity_marker": [160, 166], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_1_3", "text": "Allelic and non-allelic heterogeneities in @DISEASE$ revealed by @GENE$ mutational analysis.", "text_with_entity_marker": "Allelic and non-allelic heterogeneities in [E1]@DISEASE$[/E1] revealed by [E2]@GENE$[/E2] mutational analysis.", "text_with_typed_entity_marker": "Allelic and non-allelic heterogeneities in [DISEASE]@DISEASE$[/DISEASE] revealed by [GENE]@GENE$[/GENE] mutational analysis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [43, 52], "entity_1_idx_in_text_with_entity_marker": [47, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 61], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [65, 71], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_idx_in_text_with_typed_entity_marker": [90, 96], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_1_4", "text": "Recently, mutations have been identified in the @GENE$ gene in Caucasian families with @DISEASE$.", "text_with_entity_marker": "Recently, mutations have been identified in the [E1]@GENE$[/E1] gene in Caucasian families with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Recently, mutations have been identified in the [GENE]@GENE$[/GENE] gene in Caucasian families with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_5", "text": "@GENE$ is a major enzyme in the bioactivation of exogenous procarcinogens of @DISEASE$ (HCC).", "text_with_entity_marker": "[E1]@GENE$[/E1] is a major enzyme in the bioactivation of exogenous procarcinogens of [E2]@DISEASE$[/E2] (HCC).", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] is a major enzyme in the bioactivation of exogenous procarcinogens of [DISEASE]@DISEASE$[/DISEASE] (HCC).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_6", "text": "However, the contribution of common genetic variants in @GENE$ to the @DISEASE$ risk in Chinese populations has not been thoroughly investigated.", "text_with_entity_marker": "However, the contribution of common genetic variants in [E1]@GENE$[/E1] to the [E2]@DISEASE$[/E2] risk in Chinese populations has not been thoroughly investigated.", "text_with_typed_entity_marker": "However, the contribution of common genetic variants in [GENE]@GENE$[/GENE] to the [DISEASE]@DISEASE$[/DISEASE] risk in Chinese populations has not been thoroughly investigated.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_7", "text": "@GENE$ is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (@DISEASE$).", "text_with_entity_marker": "[E1]@GENE$[/E1] is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma ([E2]@DISEASE$[/E2]).", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma ([DISEASE]@DISEASE$[/DISEASE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_8", "text": "Interestingly, the diplotype @GENE$ also conferred an increased risk of @DISEASE$ (OR 1.76, 95% CI 1.22-2.54, P=0.003).", "text_with_entity_marker": "Interestingly, the diplotype [E1]@GENE$[/E1] also conferred an increased risk of [E2]@DISEASE$[/E2] (OR 1.76, 95% CI 1.22-2.54, P=0.003).", "text_with_typed_entity_marker": "Interestingly, the diplotype [GENE]@GENE$[/GENE] also conferred an increased risk of [DISEASE]@DISEASE$[/DISEASE] (OR 1.76, 95% CI 1.22-2.54, P=0.003).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [29, 35], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_idx_in_text_with_typed_entity_marker": [35, 41], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [72, 81], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_idx_in_text_with_typed_entity_marker": [94, 103], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_9", "text": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and @GENE$ variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "text_with_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and [E1]@GENE$[/E1] variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [E2]@DISEASE$[/E2] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "text_with_typed_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and [GENE]@GENE$[/GENE] variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [DISEASE]@DISEASE$[/DISEASE] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [110, 116], "entity_1_idx_in_text_with_entity_marker": [114, 120], "entity_1_idx_in_text_with_typed_entity_marker": [116, 122], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_10", "text": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of @GENE$ variant.", "text_with_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [E1]@DISEASE$[/E1] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of [E2]@GENE$[/E2] variant.", "text_with_typed_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [DISEASE]@DISEASE$[/DISEASE] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of [GENE]@GENE$[/GENE] variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [188, 197], "entity_1_idx_in_text_with_entity_marker": [192, 201], "entity_1_idx_in_text_with_typed_entity_marker": [197, 206], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [265, 271], "entity_2_idx_in_text_with_entity_marker": [278, 284], "entity_2_idx_in_text_with_typed_entity_marker": [290, 296], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_1_11", "text": "Compared to the most common @GENE$ haplotype CCAG, the haplotype TTGC conferred an increased risk of @DISEASE$ (OR 1.26, 95% CI 1.04-1.52).", "text_with_entity_marker": "Compared to the most common [E1]@GENE$[/E1] haplotype CCAG, the haplotype TTGC conferred an increased risk of [E2]@DISEASE$[/E2] (OR 1.26, 95% CI 1.04-1.52).", "text_with_typed_entity_marker": "Compared to the most common [GENE]@GENE$[/GENE] haplotype CCAG, the haplotype TTGC conferred an increased risk of [DISEASE]@DISEASE$[/DISEASE] (OR 1.26, 95% CI 1.04-1.52).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_12", "text": "In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of @GENE$ haplotypes/diplotypes in 1006 pathologically confirmed @DISEASE$ patients and 1015 cancer-free controls, from a Han Chinese population.", "text_with_entity_marker": "In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of [E1]@GENE$[/E1] haplotypes/diplotypes in 1006 pathologically confirmed [E2]@DISEASE$[/E2] patients and 1015 cancer-free controls, from a Han Chinese population.", "text_with_typed_entity_marker": "In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of [GENE]@GENE$[/GENE] haplotypes/diplotypes in 1006 pathologically confirmed [DISEASE]@DISEASE$[/DISEASE] patients and 1015 cancer-free controls, from a Han Chinese population.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [147, 153], "entity_1_idx_in_text_with_entity_marker": [151, 157], "entity_1_idx_in_text_with_typed_entity_marker": [153, 159], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [209, 218], "entity_2_idx_in_text_with_entity_marker": [222, 231], "entity_2_idx_in_text_with_typed_entity_marker": [231, 240], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_13", "text": "Our results suggested that common genetic variants in @GENE$ may modulate the risk of developing @DISEASE$ in the study population, particularly in non-smokers.", "text_with_entity_marker": "Our results suggested that common genetic variants in [E1]@GENE$[/E1] may modulate the risk of developing [E2]@DISEASE$[/E2] in the study population, particularly in non-smokers.", "text_with_typed_entity_marker": "Our results suggested that common genetic variants in [GENE]@GENE$[/GENE] may modulate the risk of developing [DISEASE]@DISEASE$[/DISEASE] in the study population, particularly in non-smokers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [54, 60], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 66], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_14", "text": "@GENE$ (Abeta) levels are elevated in the brain of @DISEASE$ patients.", "text_with_entity_marker": "[E1]@GENE$[/E1] (Abeta) levels are elevated in the brain of [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] (Abeta) levels are elevated in the brain of [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [51, 60], "entity_2_idx_in_text_with_entity_marker": [64, 73], "entity_2_idx_in_text_with_typed_entity_marker": [73, 82], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_15", "text": "Amyloid beta protein (@GENE$) levels are elevated in the brain of @DISEASE$ patients.", "text_with_entity_marker": "Amyloid beta protein ([E1]@GENE$[/E1]) levels are elevated in the brain of [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "Amyloid beta protein ([GENE]@GENE$[/GENE]) levels are elevated in the brain of [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [66, 75], "entity_2_idx_in_text_with_entity_marker": [79, 88], "entity_2_idx_in_text_with_typed_entity_marker": [88, 97], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_16", "text": "Anti-@GENE$ antibody passage across the blood-brain barrier in the SAMP8 mouse model of @DISEASE$: an age-related selective uptake with reversal of learning impairment.", "text_with_entity_marker": "Anti-[E1]@GENE$[/E1] antibody passage across the blood-brain barrier in the SAMP8 mouse model of [E2]@DISEASE$[/E2]: an age-related selective uptake with reversal of learning impairment.", "text_with_typed_entity_marker": "Anti-[GENE]@GENE$[/GENE] antibody passage across the blood-brain barrier in the SAMP8 mouse model of [DISEASE]@DISEASE$[/DISEASE]: an age-related selective uptake with reversal of learning impairment.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [5, 11], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_idx_in_text_with_typed_entity_marker": [11, 17], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_17", "text": "The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced @DISEASE$ indicate that patients whose tumors were wild-type, but not mutant, for @GENE$ obtained the most clinical benefit from this combination therapy.", "text_with_entity_marker": "The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced [E1]@DISEASE$[/E1] indicate that patients whose tumors were wild-type, but not mutant, for [E2]@GENE$[/E2] obtained the most clinical benefit from this combination therapy.", "text_with_typed_entity_marker": "The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced [DISEASE]@DISEASE$[/DISEASE] indicate that patients whose tumors were wild-type, but not mutant, for [GENE]@GENE$[/GENE] obtained the most clinical benefit from this combination therapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [175, 184], "entity_1_idx_in_text_with_entity_marker": [179, 188], "entity_1_idx_in_text_with_typed_entity_marker": [184, 193], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [257, 263], "entity_2_idx_in_text_with_entity_marker": [270, 276], "entity_2_idx_in_text_with_typed_entity_marker": [282, 288], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_1_18", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (@GENE$ in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([E1]@GENE$[/E1] in the etiopathogenesis of inflammatory bowel diseases ([E2]@DISEASE$[/E2]), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([GENE]@GENE$[/GENE] in the etiopathogenesis of inflammatory bowel diseases ([DISEASE]@DISEASE$[/DISEASE]), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [223, 229], "entity_1_idx_in_text_with_entity_marker": [227, 233], "entity_1_idx_in_text_with_typed_entity_marker": [229, 235], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [286, 295], "entity_2_idx_in_text_with_entity_marker": [299, 308], "entity_2_idx_in_text_with_typed_entity_marker": [308, 317], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_19", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (@GENE$ in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([E1]@GENE$[/E1] in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([GENE]@GENE$[/GENE] in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [223, 229], "entity_1_idx_in_text_with_entity_marker": [227, 233], "entity_1_idx_in_text_with_typed_entity_marker": [229, 235], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [257, 266], "entity_2_idx_in_text_with_entity_marker": [270, 279], "entity_2_idx_in_text_with_typed_entity_marker": [279, 288], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_20", "text": "The @GENE$ in women and T in men at SNP +372 T/C was found to increase @DISEASE$ susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The [E1]@GENE$[/E1] in women and T in men at SNP +372 T/C was found to increase [E2]@DISEASE$[/E2] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] in women and T in men at SNP +372 T/C was found to increase [DISEASE]@DISEASE$[/DISEASE] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [71, 80], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_idx_in_text_with_typed_entity_marker": [93, 102], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_21", "text": "The @GENE$ in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of @DISEASE$ during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The [E1]@GENE$[/E1] in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of [E2]@DISEASE$[/E2] during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of [DISEASE]@DISEASE$[/DISEASE] during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [225, 234], "entity_2_idx_in_text_with_entity_marker": [238, 247], "entity_2_idx_in_text_with_typed_entity_marker": [247, 256], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_22", "text": "The @GENE$ increased the chance of stenotic complications in @DISEASE$ during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "text_with_entity_marker": "The [E1]@GENE$[/E1] increased the chance of stenotic complications in [E2]@DISEASE$[/E2] during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] increased the chance of stenotic complications in [DISEASE]@DISEASE$[/DISEASE] during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [61, 70], "entity_2_idx_in_text_with_entity_marker": [74, 83], "entity_2_idx_in_text_with_typed_entity_marker": [83, 92], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_23", "text": "Allelic composition at the examined SNPs in genes coding for @GENE$ and MMP-3 affect @DISEASE$ susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_entity_marker": "Allelic composition at the examined SNPs in genes coding for [E1]@GENE$[/E1] and MMP-3 affect [E2]@DISEASE$[/E2] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_typed_entity_marker": "Allelic composition at the examined SNPs in genes coding for [GENE]@GENE$[/GENE] and MMP-3 affect [DISEASE]@DISEASE$[/DISEASE] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [85, 94], "entity_2_idx_in_text_with_entity_marker": [98, 107], "entity_2_idx_in_text_with_typed_entity_marker": [107, 116], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_24", "text": "Allelic composition at the examined SNPs in genes coding for TIMP-1 and @GENE$ affect @DISEASE$ susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_entity_marker": "Allelic composition at the examined SNPs in genes coding for TIMP-1 and [E1]@GENE$[/E1] affect [E2]@DISEASE$[/E2] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_typed_entity_marker": "Allelic composition at the examined SNPs in genes coding for TIMP-1 and [GENE]@GENE$[/GENE] affect [DISEASE]@DISEASE$[/DISEASE] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [72, 78], "entity_1_idx_in_text_with_entity_marker": [76, 82], "entity_1_idx_in_text_with_typed_entity_marker": [78, 84], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_25", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [E1]@GENE$[/E1] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases ([E2]@DISEASE$[/E2]), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [GENE]@GENE$[/GENE] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases ([DISEASE]@DISEASE$[/DISEASE]), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [143, 149], "entity_1_idx_in_text_with_entity_marker": [147, 153], "entity_1_idx_in_text_with_typed_entity_marker": [149, 155], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [257, 266], "entity_2_idx_in_text_with_entity_marker": [270, 279], "entity_2_idx_in_text_with_typed_entity_marker": [279, 288], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_26", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and @GENE$ (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [E1]@GENE$[/E1] (TNF)-alpha in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [GENE]@GENE$[/GENE] (TNF)-alpha in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [200, 206], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_idx_in_text_with_typed_entity_marker": [206, 212], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [246, 255], "entity_2_idx_in_text_with_entity_marker": [259, 268], "entity_2_idx_in_text_with_typed_entity_marker": [268, 277], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_27", "text": "The TIMP-1 genotype TT in women and T in men at @GENE$ was found to increase @DISEASE$ susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The TIMP-1 genotype TT in women and T in men at [E1]@GENE$[/E1] was found to increase [E2]@DISEASE$[/E2] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The TIMP-1 genotype TT in women and T in men at [GENE]@GENE$[/GENE] was found to increase [DISEASE]@DISEASE$[/DISEASE] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_28", "text": "Ala394Thr polymorphism in the clock gene @GENE$: a circadian modifier for the risk of @DISEASE$.", "text_with_entity_marker": "Ala394Thr polymorphism in the clock gene [E1]@GENE$[/E1]: a circadian modifier for the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Ala394Thr polymorphism in the clock gene [GENE]@GENE$[/GENE]: a circadian modifier for the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [41, 47], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 53], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_29", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (@DISEASE$) or bloody diarrhea than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome ([E2]@DISEASE$[/E2]) or bloody diarrhea than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome ([DISEASE]@DISEASE$[/DISEASE]) or bloody diarrhea than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [120, 129], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_idx_in_text_with_typed_entity_marker": [142, 151], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_30", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of @DISEASE$ (HUS) or bloody diarrhea than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of [E2]@DISEASE$[/E2] (HUS) or bloody diarrhea than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of [DISEASE]@DISEASE$[/DISEASE] (HUS) or bloody diarrhea than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [93, 102], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_idx_in_text_with_typed_entity_marker": [115, 124], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_31", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or @DISEASE$ than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or [E2]@DISEASE$[/E2] than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or [DISEASE]@DISEASE$[/DISEASE] than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_32", "text": "We conclude that stx genotype is one of the important factors of clinical outcome of @DISEASE$ and that pathogenicity for humans was higher in the @GENE$ genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "text_with_entity_marker": "We conclude that stx genotype is one of the important factors of clinical outcome of [E1]@DISEASE$[/E1] and that pathogenicity for humans was higher in the [E2]@GENE$[/E2] genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "text_with_typed_entity_marker": "We conclude that stx genotype is one of the important factors of clinical outcome of [DISEASE]@DISEASE$[/DISEASE] and that pathogenicity for humans was higher in the [GENE]@GENE$[/GENE] genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [147, 153], "entity_2_idx_in_text_with_entity_marker": [160, 166], "entity_2_idx_in_text_with_typed_entity_marker": [172, 178], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_1_33", "text": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the @GENE$ gene revealed one SNP and one haplotype associated with the phenotype of @DISEASE$ in the CVCR sample.", "text_with_entity_marker": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the [E1]@GENE$[/E1] gene revealed one SNP and one haplotype associated with the phenotype of [E2]@DISEASE$[/E2] in the CVCR sample.", "text_with_typed_entity_marker": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the [GENE]@GENE$[/GENE] gene revealed one SNP and one haplotype associated with the phenotype of [DISEASE]@DISEASE$[/DISEASE] in the CVCR sample.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [81, 87], "entity_1_idx_in_text_with_entity_marker": [85, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 93], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [161, 170], "entity_2_idx_in_text_with_entity_marker": [174, 183], "entity_2_idx_in_text_with_typed_entity_marker": [183, 192], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_34", "text": "@GENE$ interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and @DISEASE$, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_entity_marker": "[E1]@GENE$[/E1] interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and [E2]@DISEASE$[/E2], and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and [DISEASE]@DISEASE$[/DISEASE], and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [114, 123], "entity_2_idx_in_text_with_entity_marker": [127, 136], "entity_2_idx_in_text_with_typed_entity_marker": [136, 145], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_35", "text": "@GENE$ interacts directly with the malate shuttle system, which has been shown to be altered in @DISEASE$ and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_entity_marker": "[E1]@GENE$[/E1] interacts directly with the malate shuttle system, which has been shown to be altered in [E2]@DISEASE$[/E2] and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] interacts directly with the malate shuttle system, which has been shown to be altered in [DISEASE]@DISEASE$[/DISEASE] and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [96, 105], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_idx_in_text_with_typed_entity_marker": [118, 127], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_1_36", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both @DISEASE$ and manic disorders, including schizophrenia and bipolar disorder.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both [E2]@DISEASE$[/E2] and manic disorders, including schizophrenia and bipolar disorder.", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both [DISEASE]@DISEASE$[/DISEASE] and manic disorders, including schizophrenia and bipolar disorder.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
